======= MEIS1 ======= == Gene Information == * **Official Symbol**: MEIS1 * **Official Name**: Meis homeobox 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4211|4211]] * **UniProt**: [[https://www.uniprot.org/uniprot/O00470|O00470]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MEIS1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MEIS1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601739|Open OMIM]] == Function Summary == * **Entrez Summary**: Homeobox genes, of which the most well-characterized category is represented by the HOX genes, play a crucial role in normal development. In addition, several homeoproteins are involved in neoplasia. This gene encodes a homeobox protein belonging to the TALE ('three amino acid loop extension') family of homeodomain-containing proteins. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Acts as a transcriptional regulator of PAX6. Acts as a transcriptional activator of PF4 in complex with PBX1 or PBX2. Required for hematopoiesis, megakaryocyte lineage development and vascular patterning. May function as a cofactor for HOXA7 and HOXA9 in the induction of myeloid leukemias. {ECO:0000269|PubMed:12609849}. |Homeobox KN| |Homeobox| |negative regulation of cardiac muscle cell proliferation| |megakaryocyte development| |definitive hemopoiesis| |megakaryocyte differentiation| |lens morphogenesis in camera-type eye| |negative regulation of heart growth| |negative regulation of cardiac muscle tissue growth| |bone cell development| |negative regulation of organ growth| |negative regulation of cardiac muscle tissue development| |regulation of cardiac muscle cell proliferation| |negative regulation of striated muscle tissue development| |negative regulation of muscle organ development| |negative regulation of muscle tissue development| |regulation of cardiac muscle tissue growth| |myeloid cell development| |regulation of heart growth| |negative regulation of myeloid cell differentiation| |lens development in camera-type eye| |regulation of cardiac muscle tissue development| |regulation of organ growth| |negative regulation of developmental growth| |camera-type eye morphogenesis| |regulation of striated muscle tissue development| |regulation of muscle tissue development| |regulation of muscle organ development| |negative regulation of hemopoiesis| |eye morphogenesis| |locomotory behavior| |bone development| |transcription factor complex| |myeloid cell differentiation| |negative regulation of neuron differentiation| |regulation of myeloid cell differentiation| |negative regulation of growth| |sensory organ morphogenesis| |negative regulation of neurogenesis| |negative regulation of nervous system development| |camera-type eye development| |angiogenesis| |regulation of developmental growth| |negative regulation of cell development| |eye development| |visual system development| |sensory system development| |chromatin binding| |blood vessel morphogenesis| |negative regulation of immune system process| |DNA-binding transcription activator activity, RNA polymerase II-specific| |regulation of hemopoiesis| |blood vessel development| |protein heterodimerization activity| |skeletal system development| |RNA polymerase II proximal promoter sequence-specific DNA binding| |vasculature development| |cardiovascular system development| |sensory organ development| |hemopoiesis| |behavior| |hematopoietic or lymphoid organ development| |immune system development| |tube morphogenesis| |regulation of neuron differentiation| |regulation of growth| |negative regulation of cell population proliferation| |negative regulation of cell differentiation| |regulation of neurogenesis| |tube development| |circulatory system development| |anatomical structure formation involved in morphogenesis| |regulation of nervous system development| |regulation of cell development| |negative regulation of developmental process| |animal organ morphogenesis| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |DNA binding| |generation of neurons| |positive regulation of transcription, DNA-templated| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of cell population proliferation| |neurogenesis| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cell development| |regulation of immune system process| |positive regulation of RNA metabolic process| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp288|HMS-I2 10μM R06 exp288]]|-1.86| ^Gene^Correlation^ |[[:human genes:r:rrm1|RRM1]]|0.408| Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 14840 * **Expression level (log2 read counts)**: 0.33 {{:chemogenomics:nalm6 dist.png?nolink |}}